Optimizing lung cancer radiation treatment worldwide in COVID-19 outbreak

This publication has 50 references indexed in Scilit:

• Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial
  The Lancet, 2015
• Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer
  Annals of Oncology, 2013
• Prognostic Impact of Radiation Therapy to the Primary Tumor in Patients With Non-small Cell Lung Cancer and Oligometastasis at Diagnosis
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
• A meta‐analysis evaluating stereotactic radiosurgery, whole‐brain radiotherapy, or both for patients presenting with a limited number of brain metastases
  Cancer, 2011
• Chest Wall Toxicity After Stereotactic Body Radiotherapy for Malignant Lesions of the Lung and Liver
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
• Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial
  The Lancet Oncology, 2009
• A Phase III Trial Evaluating the Combination of Cisplatin, Etoposide, and Radiation Therapy With or Without Tamoxifen in Patients With Limited-Stage Small Cell Lung Cancer
  American Journal of Clinical Oncology, 2005
• Postoperative radiotherapy in non-small-cell lung cancer: update of an individual patient data meta-analysis
  Lung Cancer, 2005
• Prophylactic Cranial Irradiation for Patients with Small-Cell Lung Cancer in Complete Remission
  New England Journal of Medicine, 1999
• Postoperative Radiotherapy in the Treatment of Single Metastases to the Brain
  JAMA, 1998